Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedAn NIH grant/contract entry for 2018 was added to the study's identifiers section. This clarifies the funding source associated with the trial and enhances transparency of sponsorship.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays Revision: v3.6.5 in place of v3.6.4, indicating a version update for the page. This appears to be a maintenance update rather than a change to study content.SummaryDifference0.0%

- Check32 days agoChange DetectedFooter now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a site version update. The change does not modify study information or other visible content.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3 on the page. This reflects a metadata/version update rather than a substantive change to study details.SummaryDifference0.0%

- Check75 days agoChange DetectedEnrollment status was updated to indicate no participant recruitment is currently ongoing. New user-focused sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and a revision note (Revision: v3.6.0) was included.SummaryDifference0.3%

- Check83 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a behind-the-scenes update to the site; no study information or results are affected.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.